首页> 美国卫生研究院文献>Oncotarget >Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq
【2h】

Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq

机译:RNA-seq技术筛选肝癌转移外周血单个核细胞中有效的差异表达基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor metastasis is a multistep process involving a number of genetic alterations so that the genetic diagnosis is got increasingly attentions today. The aim of this study was to use RNA-seq to screen the effective differential expression genes in the peripheral blood mononuclear cells for the hepatic carcinoma with metastasis. The results showed that hepatic carcinoma samples gathered according to different metastasis. CCL3, CCL3L1, JUN, IL8, and IL1B were identified in inflammation mediated by chemokine and cytokine signaling pathway () in the hepatic carcinoma samples with metastasis, and subsequently confirmed by quantitative real-time polymerase chain reaction. In conclusions, CCL3, CCL3L1, JUN, IL8, and IL1B have the potential to be considered as candidates for future molecular diagnosis of the hepatic carcinoma with metastasis. This work may provide us with new visions into the metastasis process and potential efficient clinical diagnosis in the future.
机译:肿瘤转移是一个多步骤的过程,涉及许多遗传改变,因此遗传诊断在当今越来越受到重视。这项研究的目的是使用RNA-seq筛选转移性肝癌外周血单个核细胞中有效的差异表达基因。结果表明,肝癌标本根据转移的不同而不同。 CCL3,CCL3L1,JUN,IL8和IL1B在具有转移的肝癌样品中由趋化因子和细胞因子信号通路介导的炎症中被鉴定,随后通过实时定量聚合酶链反应进行了证实。总之,CCL3,CCL3L1,JUN,IL8和IL1B有潜力被视为将来对转移性肝癌进行分子诊断的候选药物。这项工作可能会为我们提供有关转移过程和未来潜在有效临床诊断的新视野。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号